These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
4. Effects of beta-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Folin M; Baiguera S; Tommasini M; Guidolin D; Conconi MT; De Carlo E; Nussdorfer GG; Parnigotto PP Int J Mol Med; 2005 Jun; 15(6):929-35. PubMed ID: 15870895 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Schaeffer V; Meyer L; Patte-Mensah C; Eckert A; Mensah-Nyagan AG Neurochem Int; 2008 May; 52(6):948-55. PubMed ID: 18295935 [TBL] [Abstract][Full Text] [Related]
6. Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability. Wang YP; Wang ZF; Zhang YC; Tian Q; Wang JZ Cell Res; 2004 Dec; 14(6):467-72. PubMed ID: 15625013 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profile in beta-amyloid-treated SH-SY5Y neuroblastoma cells. Martínez T; Pascual A Brain Res Bull; 2007 May; 72(4-6):225-31. PubMed ID: 17452285 [TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387 [TBL] [Abstract][Full Text] [Related]
10. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid. Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756 [TBL] [Abstract][Full Text] [Related]
13. Active immunization trial in Abeta42-injected P301L tau transgenic mice. Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870 [TBL] [Abstract][Full Text] [Related]
14. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
15. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site. Flood F; Murphy S; Cowburn RF; Lannfelt L; Walker B; Johnston JA Biochem J; 2005 Jan; 385(Pt 2):545-50. PubMed ID: 15473868 [TBL] [Abstract][Full Text] [Related]
16. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity. Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333 [TBL] [Abstract][Full Text] [Related]
17. Neuropathology of synthetic beta-amyloid peptide analogs in vivo. Chen SY; Harding JW; Barnes CD Brain Res; 1996 Apr; 715(1-2):44-50. PubMed ID: 8739621 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin reduces caspase-3 activity and up-regulates alpha-secretase in human neuroblastoma SH-SY5Y cells exposed to A beta. Famer D; Crisby M Neurosci Lett; 2004 Nov; 371(2-3):209-14. PubMed ID: 15519759 [TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid peptides 1-40betaA and 25-35betaA suppress human amylin-mediated death of RINm5F islet beta-cells with distinct actions on fibril formation. Bai JZ Cell Biol Int; 2008 Apr; 32(4):447-55. PubMed ID: 18291688 [TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Huang J; May JM Brain Res; 2006 Jun; 1097(1):52-8. PubMed ID: 16725131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]